Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;65(1):63-72.
doi: 10.1007/s11418-010-0458-x. Epub 2010 Aug 27.

The roots of Nardostachys jatamansi inhibits lipopolysaccharide-induced endotoxin shock

Affiliations

The roots of Nardostachys jatamansi inhibits lipopolysaccharide-induced endotoxin shock

Gi-Sang Bae et al. J Nat Med. 2011 Jan.

Abstract

Nardostachys jatamansi (NJ) has been used in the treatment of inflammatory diseases. However, it is not clear how NJ produces anti-inflammatory effects. In the present study, using an experimental model of lipopolysaccharide (LPS)-induced endotoxin shock, the protective effects and mechanisms of action of NJ were investigated. The water extract of roots of NJ was administrated to mice orally (1, 5, and 10 mg/kg) 1 h after or before LPS challenge. The administration of NJ inhibited LPS-induced endotoxin shock and the production of inflammatory mediators, such as interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and interferon (IFN)-α/β. Murine peritoneal macrophages were used to determine the production of inflammatory mediators. In peritoneal macrophages, NJ also inhibited LPS-induced production of inflammatory mediators, such as IL-1β, IL-6, TNF-α, and IFN-α/β. In addition, NJ reduced the activation of mitogen-activated protein kinases (MAPKs) and the level of expression of interferon regulatory factor (IRF)-1 and IRF-7 mRNA. Furthermore, post-treatment with NJ reduced LPS-induced endotoxin shock and the production of inflammatory mediators. These results suggest that NJ inhibits endotoxin shock by inhibiting the production of IL-1β, IL-6, TNF-α, and IFN-α/β through the inhibition of MAPKs activation and IRF induction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Biochem Behav. 2006 Jan;83(1):150-60 - PubMed
    1. Cell. 1996 Feb 9;84(3):443-50 - PubMed
    1. Cell Mol Immunol. 2005 Feb;2(1):20-7 - PubMed
    1. Cell Mol Immunol. 2006 Feb;3(1):21-8 - PubMed
    1. Res Immunol. 1992 Sep;143(7):759-63 - PubMed

Publication types

LinkOut - more resources